A L M Tavy1, A F J de Bruin2, K van der Sloot3, E C Boerma4, C Ince5, P G Noordzij2, D Boerma6, M van Iterson2. 1. Department of Anesthesiology, Intensive Care and Pain Medicine, St. Antonius Hospital, Postbus 2500, 3430 EM, Nieuwegein, The Netherlands. a.l.m.tavy@gmail.com. 2. Department of Anesthesiology, Intensive Care and Pain Medicine, St. Antonius Hospital, Postbus 2500, 3430 EM, Nieuwegein, The Netherlands. 3. Department of Anesthesiology and Pain Medicine, The Hague Medical Center, The Hague, The Netherlands. 4. Department of Intensive Care, Medical Center Leeuwarden, Leeuwarden, The Netherlands. 5. Department of Translational Physiology, Academic Medical Center, Amsterdam, The Netherlands. 6. Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.
Abstract
BACKGROUND: The effect of thoracic epidural analgesia (TEA) on splanchnic blood flow during abdominal surgery remains unclear. The purpose of this study was to examine whether the hemodynamic effects of TEA resulted in microcirculatory alterations to the intestinal serosa, which was visualized using incident dark-field (IDF) videomicroscopy. METHODS: An observational cohort study was performed. In 18 patients, the microcirculation of the intestinal serosa was visualized with IDF. Microcirculatory and hemodynamic measurements were performed prior to (T1) and after administering a bolus of levobupivacaine (T2). If correction of blood pressure was indicated, a third measurement was performed (T3). The following microcirculatory parameters were calculated: microvascular flow index, proportion of perfused vessels, perfused vessel density and total vessel density. Data are presented as median [IQR]. RESULTS: Mean arterial pressure decreased from 73 mmHg (68-83) at T1 to 63 mmHg (±11) at T2 (p = 0.001) with a systolic blood pressure of 114 mmHg (98-128) and 87 (81-97), respectively (p = 0.001). The microcirculatory parameters of the bowel serosa, however, were unaltered. In seven patients, blood pressure was corrected to baseline values from a MAP of 56 mmHg (55-57), while microcirculatory parameters remained constant. CONCLUSION: We examined the effects of TEA on the intestinal serosal microcirculation during abdominal surgery using IDF imaging for the first time in patients. Regardless of a marked decrease in hemodynamics, microcirculatory parameters of the bowel serosa were not significantly affected. TRIAL REGISTRY NUMBER: ClinicalTrials.gov identifier NCT02688946.
BACKGROUND: The effect of thoracic epidural analgesia (TEA) on splanchnic blood flow during abdominal surgery remains unclear. The purpose of this study was to examine whether the hemodynamic effects of TEA resulted in microcirculatory alterations to the intestinal serosa, which was visualized using incident dark-field (IDF) videomicroscopy. METHODS: An observational cohort study was performed. In 18 patients, the microcirculation of the intestinal serosa was visualized with IDF. Microcirculatory and hemodynamic measurements were performed prior to (T1) and after administering a bolus of levobupivacaine (T2). If correction of blood pressure was indicated, a third measurement was performed (T3). The following microcirculatory parameters were calculated: microvascular flow index, proportion of perfused vessels, perfused vessel density and total vessel density. Data are presented as median [IQR]. RESULTS: Mean arterial pressure decreased from 73 mmHg (68-83) at T1 to 63 mmHg (±11) at T2 (p = 0.001) with a systolic blood pressure of 114 mmHg (98-128) and 87 (81-97), respectively (p = 0.001). The microcirculatory parameters of the bowel serosa, however, were unaltered. In seven patients, blood pressure was corrected to baseline values from a MAP of 56 mmHg (55-57), while microcirculatory parameters remained constant. CONCLUSION: We examined the effects of TEA on the intestinal serosal microcirculation during abdominal surgery using IDF imaging for the first time in patients. Regardless of a marked decrease in hemodynamics, microcirculatory parameters of the bowel serosa were not significantly affected. TRIAL REGISTRY NUMBER: ClinicalTrials.gov identifier NCT02688946.
Authors: K C H Fearon; O Ljungqvist; M Von Meyenfeldt; A Revhaug; C H C Dejong; K Lassen; J Nygren; J Hausel; M Soop; J Andersen; H Kehlet Journal: Clin Nutr Date: 2005-04-21 Impact factor: 7.324
Authors: Rikard Ambrus; Michael P Achiam; Niels H Secher; Morten B S Svendsen; Kim Rünitz; Mette Siemsen; Lars B Svendsen Journal: J Am Coll Surg Date: 2017-06-29 Impact factor: 6.113
Authors: Martin Siegemund; Jasper van Bommel; Michiel E Stegenga; Wolfgang Studer; Mat van Iterson; Sandra Annaheim; Alexandre Mebazaa; Can Ince Journal: Anesth Analg Date: 2010-06-28 Impact factor: 5.108
Authors: Luzius B Hiltebrand; Vladimir Krejci; Marcus E tenHoevel; Andrej Banic; Gisli H Sigurdsson Journal: Anesthesiology Date: 2003-03 Impact factor: 7.892
Authors: Anthonius F J de Bruin; Arthur Tavy; Koene van der Sloot; Anke Smits; Bert Van Ramshorst; Christiaan E Boerma; Peter Kars; Peter G Noordzij; Djamila Boerma; Mat van Iterson Journal: J Vasc Res Date: 2016-10-04 Impact factor: 1.934
Authors: Darshan Pathak; Stephen H Pennefather; Glenn N Russell; Omar Al Rawi; I C Dave; Susan Gilby; Richard D Page Journal: Eur J Cardiothorac Surg Date: 2012-12-13 Impact factor: 4.191
Authors: Daniel De Backer; Steven Hollenberg; Christiaan Boerma; Peter Goedhart; Gustavo Büchele; Gustavo Ospina-Tascon; Iwan Dobbe; Can Ince Journal: Crit Care Date: 2007 Impact factor: 9.097